UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 7, 2022

Accession Number:	0001193125-22-093780
Submission Type:	POS AM
CIK: 0001817944 Company Name: Clarus Therapeutics Holdings, Inc. File Number: 333-259915